Innovar-Vet en es it fr

Innovar-Vet Brand names, Innovar-Vet Analogs

Innovar-Vet Brand Names Mixture

  • No information avaliable

Innovar-Vet Chemical_Formula


Innovar-Vet RX_link

Innovar-Vet fda sheet

Innovar-Vet msds (material safety sheet)

Innovar-Vet MSDS

Innovar-Vet Synthesis Reference

No information avaliable

Innovar-Vet Molecular Weight

166.24 g/mol

Innovar-Vet Melting Point

No information avaliable

Innovar-Vet H2O Solubility

Appreciable as liquid hydrochloride salt

Innovar-Vet State


Innovar-Vet LogP


Innovar-Vet Dosage Forms

Liquid for injection

Innovar-Vet Indication

For the differential diagnosis of myasthenia gravis and as an adjunct in the evaluation of treatment requirements in this disease. It may also be used for evaluating emergency treatment in myasthenic crises.

Innovar-Vet Pharmacology

Edrophonium is a short and rapid-acting anticholinesterase drug. Its effect is manifest within 30 to 60 seconds after injection and lasts an average of 10 minutes. Edrophonium's pharmacologic action is due primarily to the inhibition or inactivation of acetylcholinesterase at sites of cholinergic transmission. Muscarinic receptors are found throughout the body, especially on muscle. Stimulation of these receptors causes to muscle contraction. In myasthenia gravis the body's immune system destroys many of the muscarinic receptors, so that the muscle becomes less responsive to nervous stimulation. Edrophonium chloride increases the amount of acetylcholine at the nerve endings. Increased levels of acetyl choline allow the remaining receptors to function more efficiently.

Innovar-Vet Absorption

Rapidly absorbed.

Innovar-Vet side effects and Toxicity

With drugs of this type, muscarine-like symptoms (nausea, vomiting, diarrhea, sweating, increased bronchial and salivary secretions and bradycardia) often appear with overdosage (cholinergic crisis).

Innovar-Vet Patient Information

No information avaliable

Innovar-Vet Organisms Affected

Humans and other mammals